GRANULOMA

 

Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-kappaB activation.                                                                                 (abst – 2007)  http://www.ncbi.nlm.nih.gov/pubmed/17447045

 

Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5.                                                                                 (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518473/?tool=pubmed

 

Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats.                                                              (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/19931394

 

Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats     (full – 2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034677/?tool=pubmed

 

The Expression and Significance of Cannabinoid Receptor 2 in Non-infectious Granuloma and Malignant Melanoma                                                                   (abst – 2012)

http://www.res-medical.com/dermatosis-and-std/64093

 

Share a link for